(QLYS) Qualys - Overview
Stock: Asset Management, Vulnerability Management, Patch Management, Cloud Security
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 59.2% |
| Relative Tail Risk | -6.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.56 |
| Alpha | -37.67 |
| Character TTM | |
|---|---|
| Beta | 0.820 |
| Beta Downside | 0.698 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.18% |
| CAGR/Max DD | -0.07 |
Description: QLYS Qualys January 10, 2026
Qualys, Inc. (NASDAQ:QLYS) operates a cloud-native security and compliance platform that consolidates asset discovery, vulnerability management, and risk quantification across IT and OT environments. Its flagship Enterprise TruRisk Platform bundles modules such as Cybersecurity Asset Management, External Attack Surface Management, Multi-Vector Endpoint Detection and Response, and Cloud Security Posture Management, delivering continuous monitoring, automated remediation workflows, and analytics-driven risk scores.
Beyond large enterprises, Qualys serves government agencies, SMBs, and a broad cross-section of verticals-including financial services, healthcare, and manufacturing-through direct sales and a channel ecosystem of MSSPs, cloud providers, and security consultants. The company emphasizes a unified data lake that supports asset tagging, real-time alerts, and customizable dashboards, enabling customers to prioritize remediation based on business impact.
Key recent metrics (FY 2024): revenue of $1.15 billion, representing a 14% YoY growth driven by a 19% increase in subscription ARR; gross margin stabilized around 81%; and net dollar retention exceeding 115%, indicating strong upsell and cross-sell momentum. The broader cloud-security market is expanding at a CAGR of roughly 14% through 2028, providing a tailwind for Qualys’ subscription-based model.
Analysts watch the company’s ability to maintain low churn (≈2% annual) while expanding its addressable market via emerging workloads such as Kubernetes and IaC security, which together now account for over 12% of new contract value.
For a deeper dive into how Qualys stacks up against peers, consider reviewing the analyst coverage on the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 198.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 1.96 > 1.0 |
| NWC/Revenue: 28.44% < 20% (prev 25.89%; Δ 2.55% < -1%) |
| CFO/TA 0.26 > 3% & CFO 281.5m > Net Income 198.3m |
| Net Debt (-198.0m) to EBITDA (238.6m): -0.83 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.1m) vs 12m ago -2.32% < -2% |
| Gross Margin: 82.85% > 18% (prev 0.82%; Δ 8203 % > 0.5%) |
| Asset Turnover: 64.69% > 50% (prev 62.41%; Δ 2.28% > 0%) |
| Interest Coverage Ratio: -2.15 > 6 (EBITDA TTM 238.6m / Interest Expense TTM -78.4m) |
Altman Z'' 1.40
| A: 0.17 (Total Current Assets 657.6m - Total Current Liabilities 467.3m) / Total Assets 1.10b |
| B: -0.15 (Retained Earnings -166.7m / Total Assets 1.10b) |
| C: 0.16 (EBIT TTM 168.4m / Avg Total Assets 1.03b) |
| D: -0.32 (Book Value of Equity -170.6m / Total Liabilities 533.9m) |
| Altman-Z'' Score: 1.40 = BB |
Beneish M -3.07
| DSRI: 0.94 (Receivables 171.0m/164.6m, Revenue 669.1m/607.6m) |
| GMI: 0.99 (GM 82.85% / 81.65%) |
| AQI: 1.03 (AQ_t 0.34 / AQ_t-1 0.33) |
| SGI: 1.10 (Revenue 669.1m / 607.6m) |
| TATA: -0.08 (NI 198.3m - CFO 281.5m) / TA 1.10b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of QLYS shares?
Over the past week, the price has changed by -17.93%, over one month by -16.92%, over three months by -27.10% and over the past year by -19.54%.
Is QLYS a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the QLYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 139.3 | 25.7% |
| Analysts Target Price | 139.3 | 25.7% |
| ValueRay Target Price | 98.3 | -11.3% |
QLYS Fundamental Data Overview February 08, 2026
P/E Forward = 15.1745
P/S = 5.9771
P/B = 7.0802
P/EG = 3.0348
Revenue TTM = 669.1m USD
EBIT TTM = 168.4m USD
EBITDA TTM = 238.6m USD
Long Term Debt = 45.0m USD (estimated: total debt 52.3m - short term 7.32m)
Short Term Debt = 7.32m USD (from shortTermDebt, last quarter)
Debt = 52.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -198.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.61b USD (4.00b + Debt 52.3m - CCE 445.9m)
Interest Coverage Ratio = -2.15 (Ebit TTM 168.4m / Interest Expense TTM -78.4m)
EV/FCF = 13.29x (Enterprise Value 3.61b / FCF TTM 271.4m)
FCF Yield = 7.53% (FCF TTM 271.4m / Enterprise Value 3.61b)
FCF Margin = 40.55% (FCF TTM 271.4m / Revenue TTM 669.1m)
Net Margin = 29.64% (Net Income TTM 198.3m / Revenue TTM 669.1m)
Gross Margin = 82.85% ((Revenue TTM 669.1m - Cost of Revenue TTM 114.8m) / Revenue TTM)
Gross Margin QoQ = 83.36% (prev 83.64%)
Tobins Q-Ratio = 3.29 (Enterprise Value 3.61b / Total Assets 1.10b)
Interest Expense / Debt = 4.17% (Interest Expense 2.18m / Debt 52.3m)
Taxrate = 17.50% (11.3m / 64.4m)
NOPAT = 139.0m (EBIT 168.4m * (1 - 17.50%))
Current Ratio = 1.41 (Total Current Assets 657.6m / Total Current Liabilities 467.3m)
Debt / Equity = 0.09 (Debt 52.3m / totalStockholderEquity, last quarter 561.2m)
Debt / EBITDA = -0.83 (Net Debt -198.0m / EBITDA 238.6m)
Debt / FCF = -0.73 (Net Debt -198.0m / FCF TTM 271.4m)
Total Stockholder Equity = 524.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.17% (Net Income 198.3m / Total Assets 1.10b)
RoE = 37.83% (Net Income TTM 198.3m / Total Stockholder Equity 524.2m)
RoCE = 29.60% (EBIT 168.4m / Capital Employed (Equity 524.2m + L.T.Debt 45.0m))
RoIC = 27.15% (NOPAT 139.0m / Invested Capital 511.9m)
WACC = 8.87% (E(4.00b)/V(4.05b) * Re(8.94%) + D(52.3m)/V(4.05b) * Rd(4.17%) * (1-Tc(0.18)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.60%
[DCF Debug] Terminal Value 75.37% ; FCFF base≈251.7m ; Y1≈258.0m ; Y5≈287.1m
Fair Price DCF = 125.2 (EV 4.29b - Net Debt -198.0m = Equity 4.49b / Shares 35.9m; r=8.87% [WACC]; 5y FCF grow 2.43% → 2.90% )
EPS Correlation: 96.16 | EPS CAGR: 21.90% | SUE: 1.87 | # QB: 17
Revenue Correlation: 98.98 | Revenue CAGR: 12.31% | SUE: 1.22 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.80 | Chg30d=+0.023 | Revisions Net=+9 | Analysts=20
EPS current Year (2026-12-31): EPS=7.39 | Chg30d=+0.018 | Revisions Net=+2 | Growth EPS=+4.6% | Growth Revenue=+7.7%
EPS next Year (2027-12-31): EPS=7.95 | Chg30d=+0.096 | Revisions Net=+1 | Growth EPS=+7.5% | Growth Revenue=+6.9%